In patients who had progressed on one prior ARPI, FG3246 plus enzalutamide yielded a median radiographic progression-free survival (rPFS) of 10.1 months and PSA50 response of 40%. Phase I Monotherapy ...
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Medicine Bow Beta. Oppression leads to wealth? Grudge that a bouquet shot would be humiliating! Hot brine or dry curry leaves? Stimulus job count by doing bore well. A learner to ...
In our survey about 15 different behaviors debated in society, nine-in-ten U.S. adults say that married people having an affair is morally wrong. Republicans and Democrats differ sharply over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results